Neoadjuvant chemotherapy or primary debulking surgery in FIGO IIIC and IV patients: results from a survey study in the Netherlands

M. Timmermans*, G. S. Sonke, W. J. van Driel, R. I. Lalisang, P. B. Ottevanger, C. D. de Kroon, K. K. Van de Vijver, M. A. van der Aa, R. F. Kruitwagen

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)98-102
Number of pages5
JournalEuropean Journal of Obstetrics & Gynecology and Reproductive Biology
Volume223
DOIs
Publication statusPublished - 1 Apr 2018

Keywords

  • Epithelial ovarian cancer
  • Primary debulking surgery
  • Neoadjuvant chemotherapy
  • Survey
  • ADVANCED-STAGE OVARIAN
  • HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY
  • GYNECOLOGIC-ONCOLOGY
  • EUROPEAN-SOCIETY
  • CANCER
  • SURVIVAL
  • CISPLATIN
  • TRIAL
  • PACLITAXEL
  • MANAGEMENT

Cite this